# MiniMed Group, Inc. (MMED) · Edgar & Edgarette company card

> MiniMed Group (MMED) grew revenue 14.3% in FY2026 to $3.1 billion, operating margin -6.1% against a 1.2% median for surgical & medical instruments & apparatus, equity 78.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 2062583 · fiscal year ended 2026-04-24 · 3 audited years read · [page](https://www.pops4.com/boards/company/MMED) · [JSON](https://www.pops4.com/boards/company/MMED.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $3.1B |
| Revenue growth, 1 year | 14.3% |
| Revenue growth per year | 12.1% |
| Operating margin | -6.1% (prior year -5.4%) |
| Net margin | -10.7% |
| Operating cash flow | −$197M |
| Capital spending | $223M |
| Free cash flow | −$420M |
| Cash | $298M |
| Long-term debt | — |
| Total assets | $4.6B |
| Total equity | $3.6B |
| Equity ÷ assets | 78.0% |
| Return on equity | -9.2% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 4.28 (safe zone)
- Piotroski F: 4 of 9 (middling)
- Beneish M: -3.11 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -6.1% in FY2026
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $3.1B (FY2026). Experience: revenue up 14.3% on the year, up 12.1% a year over 2 years; operating margin -6.1%, down from -5.4%. Soundness: equity 78.0% of assets, return on equity -9.2%. Credibility: 3 audited years, moderate weight. Range: 80% of past cases like this landed between $2.8B and $4.1B next year (method v3, set from 4,599 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -6.1% against a 1.2% median; growth 14.3% against 11.6%.

Range logged 2026-09-27, receipt 18902b5f133367be, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 6, latest 2026-10-16 ([filing](https://www.sec.gov/Archives/edgar/data/2062583/000110465926116441/0001104659-26-116441-index.htm))

## Recent filings

- 8-K · filed 2026-10-16 · 5.01 Changes in Control of Registrant; 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2062583/000110465926116441/0001104659-26-116441-index.htm)
- 8-K · filed 2026-10-13 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2062583/000110465926115141/0001104659-26-115141-index.htm)
- 10-Q · filed 2026-09-08 · [filing](https://www.sec.gov/Archives/edgar/data/2062583/000162828026060926/0001628280-26-060926-index.htm)
- 8-K · filed 2026-09-01 · 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2062583/000162828026059699/0001628280-26-059699-index.htm)
- DEF 14A · filed 2026-08-21 · [filing](https://www.sec.gov/Archives/edgar/data/2062583/000114036126034021/0001140361-26-034021-index.htm)
- 8-K · filed 2026-08-05 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2062583/000110465926091115/0001104659-26-091115-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0002062583.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2062583

## Cite

POPS4, Edgar & Edgarette: MiniMed Group, Inc. (MMED) company card, from the company's own SEC filings, accessed 2026-11-12, https://www.pops4.com/boards/company/MMED. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.